Evidence map›Paper›PMID 34536414›Full record

ArticleThe Journal of allergy and clinical immunology2022

Neuroimaging and biomarker evidence of neurodegeneration in asthma.

Melissa A Rosenkranz, Douglas C Dean, Barbara B Bendlin, Nizar N Jarjour, Stephane Esnault, Henrik Zetterberg, Amanda Heslegrave, Michael D Evans, Richard J Davidson, William W Busse

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. IL7RBrain and behavior · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?The journal of allergy and clinical immunology. In practice · 2024
    Review
  15. Article
  16. Association of Plasma Claudin-5 with Age and Alzheimer Disease.International journal of molecular sciences · 2024
    Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Melissa A RosenkranzDepartment of Psychiatry, University of Wisconsin-Madison, Madison, Wisc; Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisc. Electronic address: melissa.rosenkranz@wisc.edu.
Douglas C DeanDepartment of Pediatrics, University of Wisconsin-Madison, Madison, Wisc; Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisc; Waisman Center, University of Wisconsin-Madison, Madison, Wisc.
Barbara B BendlinDepartment of Medicine, University of Wisconsin-Madison, Madison, Wisc; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, Madison, Wisc.
Nizar N JarjourDepartment of Medicine, University of Wisconsin-Madison, Madison, Wisc.
Stephane EsnaultDepartment of Medicine, University of Wisconsin-Madison, Madison, Wisc.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom; UK Dementia Research Institute at UCL, London, United Kingdom.
Amanda HeslegraveUK Dementia Research Institute at UCL, London, United Kingdom.
Michael D EvansBiostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minn.
Richard J DavidsonDepartment of Psychiatry, University of Wisconsin-Madison, Madison, Wisc; Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisc; Department of Psychology, University of Wisconsin-Madison, Madison, Wisc.
William W BusseDepartment of Medicine, University of Wisconsin-Madison, Madison, Wisc.
University of Wisconsin–Madison · USUK Dementia Research Institute · GBUniversity of Minnesota · US

Funding

Wisconsin Center for the Neuroscience and Psychophysiology of MeditationP01AT004952 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI DAVIDSON, RICHARD J · 2008 to 2018
$14.7M
Waisman Intellectual and Developmental Disabilities Research Center Down Syndrome RegistryU54HD090256 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 2016 to 2020
$6.0M
Stability of Severe Asthma Phenotypes: Impact of ExacerbationsU10HL109168 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI JARJOUR, NIZAR N · 2011 to 2016
$3.9M
Asthmatic Inflammation and Neurocircuitry ActivationR01HL123284 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BUSSE, WILLIAM W. · 2016 to 2019
$2.9M
BRAIN CONNECTIVITY AND THE ROLE OF MYELIN IN AUTISM SPECTRUM DISORDERSR00MH110596 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI DEAN III, DOUGLAS CARL · 2019 to 2021
$743k
Neural mechanisms by which chronic stress regulates inflammation in asthmaK01AT006202 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI ROSENKRANZ, MELISSA A · 2010 to 2014
$471k
NCCIH NIH HHS K01 AT006202NCCIH NIH HHS P01 AT004952NHLBI NIH HHS R01 HL123284NHLBI NIH HHS U10 HL109168NICHD NIH HHS U54 HD090256NIMH NIH HHS R00 MH110596
6 · The paper itself

Abstract

backgroundEpidemiologic studies have shown that Alzheimer's disease (AD) and related dementias (ADRD) are seen more frequently with asthma, especially with greater asthma severity or exacerbation frequency.

objectiveTo examine the changes in brain structure that may underlie this phenomenon, we examined diffusion-weighted magnetic resonance imaging (dMRI) and blood-based biomarkers of AD (phosphorylated tau 181, p-Tau181), neurodegeneration (neurofilament light chain, NfL), and glial activation (glial fibrillary acidic protein, GFAP).

methodsdMRI data were obtained in 111 individuals with asthma, ranging in disease severity from mild to severe, and 135 healthy controls. Regression analyses were used to test the relationships between asthma severity and neuroimaging measures, as well as AD pathology, neurodegeneration, and glial activation, indexed by plasma p-Tau181, NfL, and GFAP, respectively. Additional relationships were tested with cognitive function.

resultsAsthma participants had widespread and large-magnitude differences in several dMRI metrics, which were indicative of neuroinflammation and neurodegeneration, and which were robustly associated with GFAP and, to a lesser extent, NfL. The AD biomarker p-Tau181 was only minimally associated with neuroimaging outcomes. Further, asthma severity was associated with deleterious changes in neuroimaging outcomes, which in turn were associated with slower processing speed, a test of cognitive performance.

conclusionsAsthma, particularly when severe, is associated with characteristics of neuroinflammation and neurodegeneration, and may be a potential risk factor for neural injury and cognitive dysfunction. There is a need to determine how asthma may affect brain health and whether treatment directed toward characteristics of asthma associated with these risks can mitigate these effects.

Indexed as

AdolescentAdultAgedAsthmaBiomarkersDiffusion Magnetic Resonance ImagingFemaleHumansMaleMiddle AgedNeurodegenerative DiseasesNeuroimagingSeverity of Illness Indextau ProteinsYoung AdultBiomarkerstau ProteinsAsthmadementiadiffusion-weighted imagingGFAPinflammationneurodegenerationNfL

Identifiers

PMID34536414
PMCPMC8821112
OpenAlexW3199976691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.